| 产品描述: | NSAH is a reversible and competitive nonnucleoside ribonucleotide reductase (RR) inhibitor, with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively[1] |
| 靶点: |
DNA/RNA Synthesis |
| 体外研究: |
NSAH depresses dGTP and dATP levels in the dNTP pool causing S-phase arrest, providing evidence for RR inhibition in cells.
NSAH (0-10 μM, 2, 6, 24, or 72 h) exhibits potent anti-tumor activity in 3 cancer cell lines.
NSAH blocks S-phase progression well to the extent and timing of the decreases in dATP and dGTP. |
| 参考文献: |
1. Md Faiz Ahmad, et al. Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8241-8246. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 备注: |
NSAH 是可逆的、竞争性的非核苷类的核苷酸还原酶 (RR)的抑制剂,其 cell-free 和 cell-bases 的 IC50 值分别为 32 μM 和 ~250 nM。 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.265 ml |
16.323 ml |
32.645 ml |
| 5 mM |
0.653 ml |
3.265 ml |
6.529 ml |
| 10 mM |
0.326 ml |
1.632 ml |
3.265 ml |
| 50 mM |
0.065 ml |
0.326 ml |
0.653 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |